Skip to main content

Published locations for Dupilumab approval marks the first targeted treatment for AD

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Dupilumab approval marks the first targeted treatment for AD

User login

  • Reset your password
  • /content/dupilumab-approval-marks-first-targeted-treatment-ad
  • /edermatologynews/article/135905/atopic-dermatitis/dupilumab-approval-marks-first-targeted-treatment
  • /familypracticenews/article/135905/atopic-dermatitis/dupilumab-approval-marks-first-targeted
  • /internalmedicinenews/article/135905/atopic-dermatitis/dupilumab-approval-marks-first-targeted
  • /internalmedicine/article/135905/atopic-dermatitis/dupilumab-approval-marks-first-targeted-treatment
  • /dermatology/article/135905/atopic-dermatitis/dupilumab-approval-marks-first-targeted-treatment-ad
  • /familymedicine/article/135905/atopic-dermatitis/dupilumab-approval-marks-first-targeted-treatment-ad